Subscribe: Market Wire - Medical and Healthcare: Surgery and Treatments
http://img.marketwire.com/rss/mwMHSU.rss
Added By: Feedage Forager Feedage Grade B rated
Language: English
Tags:
cancer  conference lung  cáncer pulmón  câncer pulmão  des  iaslc  lung cancer  lung  marketwired dec  marketwired  wclc 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Market Wire - Medical and Healthcare: Surgery and Treatments

Marketwired - Surgery and Treatments



Marketwired - Surgery and Treatments



Last Build Date: Thu, 08 Dec 2016 19:09:22 EST

Copyright: Copyright: (C) Marketwired
 



Southern Home Medical Inc. Announces Clarification of Press Release Dated December 1, 2016

Thu, 08 Dec 2016 17:53:55 EST

NEW YORK, NY--(Marketwired - Dec 8, 2016) - Southern Home Medical Inc. (OTC PINK: SHOM), a leading developer in the Healthcare Industry, announced that it is issuing this news release to clarify the information contained in its news release titled "Southern Home Medical Inc. Subsidiary signs a Testing Contract with Coca-Cola East Japan" dated December 1, 2016. 




Zywie Receives the Two Top Awards for Innovation at Health IT Leadership Summit

Thu, 08 Dec 2016 15:58:29 EST

Next-Generation Remote Cardiac Monitoring Solution Revolutionizing Decades-Old Solution




Cherubim Interests, Inc. Subsidiary Releases Conceptual Design Of Mobile Testing and Extraction Laboratory For The Cannabis Sector

Thu, 08 Dec 2016 12:16:52 EST

DALLAS, TX--(Marketwired - Dec 8, 2016) - Budcube Cultivation Systems (BCS), a subsidiary of Cherubim Interests, Inc. (OTC PINK: CHIT) ("the Company"), an expansion-stage alternative construction and real estate development company, along with venture-partner United Cannabis Corp (OTCQB: CNAB) releases conceptual designs of their mobile testing and extraction laboratories to service the cannabis sector.




Denise Hines Receives Phoenix Award for Community Leadership

Thu, 08 Dec 2016 10:42:25 EST

ATLANTA, GA--(Marketwired - Dec 8, 2016) - Denise Hines, DHA, PMP, FHIMSS, CEO of eHealth Services Group and Executive Director of Georgia Health Information Network (GaHIN), received the Phoenix Community Leader of the Year Award at the 2016 Health IT Leadership Summit. Dr. Hines was recognized for her instrumental role in advancing healthcare connectivity in Georgia to ensure physicians have the information they need to deliver quality care.




Five Reasons to Consider a Therapeutic Farm Community

Thu, 08 Dec 2016 10:00:00 EST

MESOPOTAMIA, OH--(Marketwired - December 08, 2016) - Therapeutic farm communities such as Hopewell are known as healing places where individuals with serious mental illness can recover and be well again. Hopewell subscribes to a conceptual model of care that values the whole person -- mind, body and spirit -- treated in the context of a healthy, safe and natural environment that allows time for residents to experience a sustained recovery.




Medical Marijuana, Inc.'s HempMeds(R) to Showcase Award-Winning Hemp Oil Cannabidiol (CBD) and Cannabis Beauty Defined Products at A4M World Congress

Thu, 08 Dec 2016 09:00:00 EST

HempMeds(R) to Educate Thousands of Global Healthcare Professionals Attending the World Congress on Anti-Aging Medicine on Rapidly Emerging Hemp Cannabidiol (CBD) Industry




Functional Prototype Complete -- Imagin Medical Chooses Optel to Design i/Blue Prototype for Commercialization

Thu, 08 Dec 2016 08:00:00 EST

Imagin Medical Is the Developer of the Ultrasensitive i/Blue Imaging System That Will Establish a New Standard of Care for Urologists in Detecting Bladder Cancer Through Endoscopes




Majesco Entertainment Inc. and PolarityTE, Inc. Enter Into Merger Agreement

Thu, 08 Dec 2016 08:00:00 EST

Appoints Denver Lough, MD, PhD as Chief Executive Officer and Chairman of the Board; Appoints Edward Swanson, MD as Chief Operating Officer and Director; Executive Vice President John Stetson named Director; Majesco accepts subscription agreements for $2.25 million




Digital Marketing and Direct-to-Consumer Advertising is a Growing Component in the Pharma Industry

Thu, 08 Dec 2016 07:53:00 EST

RESEARCH TRIANGLE PARK, NC--(Marketwired - December 08, 2016) - Contrary to initial misgivings about digital and social channels, they have become an increasingly popular part of healthcare companies' marketing mixes, according to research from Cutting Edge Information.




Exosome Diagnostics Announces the First Instrument for Point of Care Liquid Biopsy

Thu, 08 Dec 2016 07:30:00 EST

CAMBRIDGE, MA--(Marketwired - December 08, 2016) - Exosome Diagnostics, Inc. announced today that it has developed the first instrument for exosomal protein (exoProtein) capture and analysis directly from any biofluid. The capabilities of this system will revolutionize drug development and point of care diagnostics using liquid biopsy.




Das Pressebriefing der 17. IASLC WCLC zeigt Fortschritte bei der Lungenkrebsbehandlung durch Immuntherapie und eine verbesserte Diagnostik

Thu, 08 Dec 2016 06:45:46 EST

WIEN, ÖSTERREICH --(Marketwired - 8. Dezember 2016) - Das heutige Pressebriefing auf der 17. IASLC (International Association for the Study of Lung Cancer) World Conference on Lung Cancer(WCLC) konzentrierte sich auf klinische Studien, die den Fortschritt bei der Behandlung von Lungenkrebs durch Immuntherapie und eine bessere Diagnostik beschleunigen. Abstracts und vollständige Versionen von Pressemitteilungen für jedes Thema sind über Links in dieser Zusammenfassung oder über den Pressevertreter der IASLC, Chris Martin, auf cmartin@davidjamesgroup.com verfügbar.




Le point-presse de la 17e WCLC de l'IASLC révèle des avancées dans le traitement du cancer du poumon grâce à l'immunothérapie et à de meilleurs diagnostics

Thu, 08 Dec 2016 00:23:47 EST

VIENNE, AUTRICHE--(Marketwired - 8 décembre 2016) - Le point-presse d'aujourd'hui à l'occasion de la 17e Conférence mondiale sur le cancer du poumon (WCLC) de l'IASLC s'est concentré sur des essais cliniques qui font progresser le traitement du cancer du poumon grâce à l'immunothérapie et à de meilleurs diagnostics. Des résumés et des versions complètes des communiqués de presse pour chaque thème couvert sont disponibles via les liens fournis dans ce résumé, ou auprès de Chris Martin, représentant de l'IASLC auprès des médias, à l'adresse : cmartin@davidjamesgroup.com.




Lice Clinics of America Appoints Krista Lauer, MD as Medical Director

Wed, 07 Dec 2016 22:00:00 EST

The Nation's Largest Network of Lice Removal Clinics Expands Senior Team




Rueda de prensa de la 17ª WCLC de la IASLC revela avances en el tratamiento del cáncer de pulmón gracias a la inmunoterapia y a mejores diagnósticos

Wed, 07 Dec 2016 21:11:45 EST

VIENA, AUSTRIA--(Marketwired - 7 de diciembre de 2016) - La rueda de prensa de hoy de la 17ª Conferencia Mundial sobre Cáncer de Pulmón (WCLC) de la IASLC se centró en ensayos clínicos que impulsan el progreso logrado en el tratamiento del cáncer de pulmón a través de la inmunoterapia y de mejores diagnósticos. Los resúmenes y las versiones completas de los comunicados de prensa de cada tema cubierto están disponibles a través de los enlaces en este resumen, o a través del representante de medios de la IASLC, Chris Martin, en cmartin@davidjamesgroup.com.




Die regelmäßige Anwendung von Ibuprofen könnte das Lungenkrebsrisiko bei hochgefährdeten Untergruppen von Zigarettenrauchern senken

Wed, 07 Dec 2016 19:19:45 EST

WIEN, ÖSTERREICH--(Marketwired - 7. Dezember 2016) - Laut den während der von der IASLC in Wien (Österreich) veranstalteten 17. Weltlungenkrebskonferenz (WCLC) präsentierten Forschungsergebnissen könnte die regelmäßige Anwendung von Ibuprofen das Lungenkrebsrisiko von Personen mit einer Rauchervergangenheit senken.




L'usage régulier de l'ibuprofène réduirait les risques de cancer du poumon chez les sous-catégories de fumeurs de cigarettes à risque élevé

Wed, 07 Dec 2016 19:13:15 EST

VIENNE, AUTRICHE--(Marketwired - 7 décembre 2016) - La consommation régulière d'ibuprofène permettrait de réduire les risques de cancer du poumon chez les patients ayant des antécédents d'usage de la cigarette ; telles sont les conclusions qui ressortent d'une étude présentée lors de la 17ème Conférence mondiale sur le cancer du poumon(WCLC) organisée par l'IASLC à Vienne (Autriche).




Coletiva com a mídia do IASLC 17th WCLC revela os avanços no tratamento de câncer de pulmão por meio da imunoterapia e melhores diagnósticos

Wed, 07 Dec 2016 17:29:22 EST

VIENNA, AUSTRIA--(Marketwired - 7 de dezembro de 2016) - A coletiva com a mídia de hoje da IASLC 17th World Conference on Lung Cancer(Conferência Mundial de Câncer de Pulmão -WCLC) concentrou-se no testes clínicos que avançam o progresso do tratamento de câncer de pulmão por meio da imunoterapia e melhores diagnósticos. Abstratos e versões completas dos releases de cada tópico estão disponíveis nos links deste resumo, ou com Chris Martin, representante de mídia da IASLC no cmartin@davidjamesgroup.com.




El uso regular de Ibuprofen puede reducir el riesgo de cáncer de pulmón entre los subgrupos de fumadores de cigarrillo de alto riesgo

Wed, 07 Dec 2016 17:11:22 EST

VIENNA, AUSTRIA--(Marketwired - 7 de diciembre de 2016) - El uso regular de ibuprofeno puede reducir el riesgo de cáncer de pulmón entre las personas con historia de haber fumado cigarrillo, según una investigación presentada en la 17ava. Conferencia Mundial sobre el Cáncer de Pulmón(WCLC) de la Asociación Internacional para el Estudio del Cáncer de Pulmón (IASLC) en Viena, Austria.




Uso regular de ibuprofeno pode reduzir o risco de Câncer de Pulmão nos subgrupos de alto risco dos fumantes de cigarro

Wed, 07 Dec 2016 15:19:28 EST

VIENNA, AUSTRIA--(Marketwired - 7 de dezembro de 2016) - O uso regular de ibuprofeno pode reduzir o risco do câncer de pulmão dos fumantes de cigarro, de acordo com a pesquisa apresentada na IASLC 17th World Conference on Lung Cancer(Conferência Mundial sobre o Câncer de Pulmão - WCLC) em Viena, Áustria.




Senate Passes Landmark 21st Century Cures Act

Wed, 07 Dec 2016 15:16:05 EST

WASHINGTON, DC--(Marketwired - December 07, 2016) - Today, the United States Senate overwhelmingly approved the 21st Century Cures Act, a game-changer for medical innovation, by a bipartisan vote of 94-5. The President is expected to sign the bill into law later this week.




DePuy Synthes, Stryker Lead Orthopedic Trauma Device Market Driven by Influx of High Cost New Technology, According to iData Research

Wed, 07 Dec 2016 12:36:45 EST

There are over 1.8 million total trauma fixation procedures performed in the United States so far this year, as a result, the orthopedic trauma device market is expected to reach over $4 billion by 2023




Proove Biosciences Unveils First Precision Medicine Genetic Test for Painful TMJ Disorder

Wed, 07 Dec 2016 12:00:00 EST

Proove Launches the Only Commercially Available Genetic Analysis Offering Personalized Medical Treatment Recommendations for TMD Sufferers and Insights Into Contributing Causes of Orofacial Pain




Independence Blue Cross Foundation announces grants supporting community health and well-being

Wed, 07 Dec 2016 12:00:00 EST

Nearly $3.1 million in funding supports community health clinics, efforts to increase survival rates for sudden cardiac arrest, and initiatives that build healthier communities




DirectTrust Directory Service Reaches Critical Mass as Directory Surpasses Half a Million Entries

Wed, 07 Dec 2016 09:23:15 EST

Directory Service enables hassle-free interoperability for Direct exchange users




Acquisitions are In-Vogue for Largest Medical Device Manufacturers

Wed, 07 Dec 2016 09:09:00 EST

Breakdown of Medical Device Acquisitions Reveals Industry Strategy




GeoVax to Conduct Investor and Partnering Meetings During 35th Annual J.P. Morgan Healthcare Conference

Wed, 07 Dec 2016 09:00:00 EST

ATLANTA, GA--(Marketwired - Dec 7, 2016) -  GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, announced today that it is scheduling investor and corporate partnering meetings during the 35th Annual J.P. Morgan Healthcare Conference, to be held in San Francisco on January 9-12, 2017.




IASLC 17th WCLC Press Briefing Reveals Advancements in Lung Cancer Treatment Through Immunotherapy and Better Diagnostics

Wed, 07 Dec 2016 09:00:00 EST

VIENNA, AUSTRIA--(Marketwired - December 07, 2016) - Today's press briefing at the IASLC 17th World Conference on Lung Cancer (WCLC) focused on clinical trials that advance the progress made in lung cancer treatment through immunotherapy and better diagnostics. Abstracts and full versions of news releases for each topic covered are available through links in this summary, or through IASLC media representative Chris Martin at cmartin@davidjamesgroup.com.




Image Protect Inc. Engages the largest Stock Photo Marijuana Site for Copyright Infringements

Wed, 07 Dec 2016 08:39:59 EST

SAN CLEMENTE, CA--(Marketwired - Dec 7, 2016) - Image Protect Inc. (OTC: IMTL)




Centralized Adaptive Trial Design Teams Promote Cross-Geography Communication

Wed, 07 Dec 2016 08:36:00 EST

RESEARCH TRIANGLE PARK, NC--(Marketwired - December 07, 2016) - A recent study released by Cutting Edge Information found that most surveyed clinical trial teams -- either global or at the country level -- report better cross-geography communication through centralized adaptive trial design decision-making structures. Establishing these centralized structures helps influence active dialogue between global and country-level teams.




Stealth Mark Opens Office in Silicon Valley to Support Tech Companies with Its Anti-Counterfeiting Technology

Wed, 07 Dec 2016 08:00:00 EST

Key Executive Retained to Expand Business Development Efforts With Top Tier Technology Companies in Silicon Valley




Regular Use of Ibuprofen May Lower Lung Cancer Risk Among High-Risk Subgroups of Cigarette Smokers

Wed, 07 Dec 2016 08:00:00 EST

VIENNA, AUSTRIA--(Marketwired - December 07, 2016) - Regular use of ibuprofen may lower the risk of lung cancer among those with a history of cigarette smoking, according to research presented at the IASLC 17th World Conference on Lung Cancer (WCLC) in Vienna, Austria.




Tauriga Sciences, Inc. Reports Progress in Completing the Formulation of its First ColluMauxil Branded Product, a Cannabidiol "CBD" Infused Roll On for Muscle Tension Relief

Wed, 07 Dec 2016 07:45:00 EST

LOS ANGELES, CA--(Marketwired - Dec 7, 2016) - Tauriga Sciences, Inc. (OTC PINK: TAUG) ("Tauriga" or the "Company"), a company engaged in building businesses in the life sciences space, has today announced that the Company has completed the formulation of RolLeaf, its proprietary CBD infused product targeting individuals who suffer from muscle tension. The Company has manufactured its first sample batch of the product. As previously disclosed, the Company is forming a new subsidiary called ColluMauxil Therapeutics LLC ("ColluMauxil") to focus on the development, marketing, and licensing of non-opioid products and product lines that specifically target muscle tension, a key component of pain.




KC Holdings Inc. a wholly owned subsidiary of SHOM is working within Kuala Lumpur focusing on healthcare companies in Malaysia

Wed, 07 Dec 2016 06:00:00 EST

NEW YORK, NY and KUALA LUMPUR, MALAYSIA--(Marketwired - Dec 7, 2016) -  Southern Home Medical, Inc. (OTC PINK: SHOM), a technology developer within the healthcare industry, has announced today that KC Holdings, Inc., a wholly owned subsidiary of SHOM, is working within Kuala Lumpur focusing on healthcare in Malaysia. Mr. George Chang, CEO of SHOM, visited Malaysia back in October to meet with Malaysian healthcare officials focusing on improving their technology. These meetings led to the role of KC Holdings, Inc. assisting healthcare companies improve throughout the country while Kuala Lumpur will continue to assist Malaysian healthcare companies' businesses development. This new focus could increase the quality of healthcare for the people of Malaysia in areas such as treatment, safety and detection of health issues.




Zusammenfassung der Forschungspräsentationen bei der 17. Welt-Lungenkrebs-Konferenz der Internationalen Vereinigung für das Studium von Lungenkrebs (International Association for the Study of Lung Cancer, IASLC) am Dienstag, dem 6. Dezember 2016

Wed, 07 Dec 2016 04:58:14 EST

WIEN, ÖSTERREICH--(Marketwired - 7. Dezember 2016) - Die heutige Presseinformation zur 17. Welt-Lungenkrebs-Konferenz (World Conference on Lung Cancer, WCLC) der IASLC setzte den Akzent auf aktive Prävention. Forscher stellten Ergebnisse klinischer Studien vor, die eine Reduzierung des Risikos einer Krankheitsprogression bei Lungenkrebspatienten gezeigt haben. Es stehen Auszüge sowie vollständige Ausgaben der Pressemitteilungen zu jedem behandelten Thema zur Verfügung, darunter der ungekürzte Artikel zur Studie AURA3, der in der heutigen Ausgabe des New England Journal of Medicine erscheint. Weitere Informationen erhalten Sie von Chris Martin, Medienbeauftragter der IASLC, unter cmartin@davidjamesgroup.com.




Resumen de las presentaciones de investigación de la 17ª Conferencia Mundial sobre el Cáncer de Pulmón de la IASLC, martes 6 de diciembre de 2016

Tue, 06 Dec 2016 22:07:17 EST

VIENA, AUSTRIA--(Marketwired - 6 de diciembre de 2016) - La rueda de prensa de hoy en la 17ª Conferencia Mundial sobre Cáncer de Pulmón (WCLC) de la IASLC se centró en la prevención activa. Los investigadores compartieron los resultados de ensayos clínicos con medicamentos que han demostrado una reducción del riesgo de progresión de la enfermedad entre pacientes con cáncer de pulmón. Se encuentran disponibles los resúmenes y las versiones completas de los comunicados de prensa sobre cada uno de los temas tratados, incluido el artículo completo sobre el ensayo AURA3 que se publicó hoy en la revista New England Journal of Medicine. Comuníquese con Chris Martin, representante de medios de la IASLC, en cmartin@davidjamesgroup.com para obtener más información.




Résumé des présentations d'études de la 17e Conférence mondiale sur le cancer du poumon de l'IASLC (mardi 6 décembre 2016)

Tue, 06 Dec 2016 20:06:04 EST

VIENNE, AUTRICHE--(Marketwired - 6 décembre 2016) - Le point-presse d'aujourd'hui à l'occasion de la 17e Conférence mondiale sur le cancer du poumon (WCLC) de l'IASLC s'est concentré sur la prévention active, avec des présentations par des chercheurs d'essais cliniques sur des médicaments ayant affiché une réduction du risque de progression de la maladie chez des patients atteints de cancer du poumon. Des résumés et des versions complètes de communiqués de presse pour chaque thème couvert sont disponibles, y compris l'article complet sur l'essai AURA3, qui est publié dans l'édition d'aujourd'hui du New England Journal of Medicine. Pour en savoir plus, veuillez contacter Chris Martin, représentant de l'IASLC auprès des médias, à l'adresse : cmartin@davidjamesgroup.com.




Resumo das Apresentações das Pesquisas na IASLC 17a Conferência Mundial sobre Câncer de Pulmão de terça-feira, dia 6 de dezembro de 2016

Tue, 06 Dec 2016 18:33:12 EST

VIENNA, AUSTRIA--(Marketwired - 6 de dezembro de 2016) - A coletiva com a mídia de hoje na IASLC 17a Conferência Mundial sobre o Câncer de Pulmão (World Conference on Lung Cancer - WCLC) concentrou-se na prevenção ativa, com os pesquisadores compartilhando os resultados dos testes clínicos com medicamentos que demonstraram a redução do risco da progressão da doença nos pacientes com câncer de pulmão. Abstratos e versões completas dos releases de cada tópico estão disponíveis, inclusive o artigo completo sobre o Teste AURA3 publicado hoje no New England Journal of Medicine. Contate Chris Martin, representante de mídia da IASLC no cmartin@davidjamesgroup.com para mais informação.




UPDATE - Prolacta Bioscience(R) Raises $35 Million in Mezzanine Financing

Tue, 06 Dec 2016 16:36:49 EST

CITY OF INDUSTRY, CA--(Marketwired - Dec 6, 2016) - Prolacta Bioscience®, the nation's leading provider of human milk-based neonatal nutritional products, today announced the closing of a $35 million mezzanine round of financing. The transaction was led by Essex Woodlands and included participation from Aisling Capital, with existing shareholder Health Evolution Partners. As part of the transaction, Martin Sutter, Co-Founder and Managing Director at Essex Woodlands, will join Prolacta's Board of Directors.




Medical Marijuana, Inc.'s Investment Company AXIM(R) Biotech Receives Approval From Medical Ethical Committee to Begin IBS Trial for CBD Product

Tue, 06 Dec 2016 12:00:00 EST

Company's Major Investment AXIM Biotech to Begin Study on Patients with IBS with the CanChew Plus(R) CBD-containing Chewing Gum




Winx Sleep Therapy System Now Available Directly to the Millions of Obstructive Sleep Apnea Sufferers Who Can't or Won't Use CPAP

Tue, 06 Dec 2016 10:00:00 EST

REDWOOD CITY, CA--(Marketwired - December 06, 2016) - ApniCure, which makes the Winx Sleep Therapy System for obstructive sleep apnea (OSA), today announces that Winx is now available for direct purchase by consumers. Winx provides relief from obstructive sleep apnea without a mask and is designed specifically for the half of sleep apnea patients who can't or won't use a CPAP (Continuous Positive Airway Pressure) machine. FDA-cleared and previously available only in select sleep labs, Winx is currently available to consumers in California due to initial high demand, but will be available with broader national distribution in 2017.




Summary of Research Presentations From the IASLC 17th World Conference on Lung Cancer Tuesday, December 6, 2016

Tue, 06 Dec 2016 09:31:06 EST

VIENNA, AUSTRIA--(Marketwired - December 06, 2016) - Today's press briefing at the IASLC 17th World Conference on Lung Cancer (WCLC) focused on active prevention, with researchers sharing results of clinical drug trials that have shown reduction in risk of disease progression among lung cancer patients. Abstracts and full versions of news releases for each topic covered are available, including the complete article on the AURA3 Trial that is published in today's New England Journal of Medicine. Contact IASLC media representative Chris Martin at cmartin@davidjamesgroup.com for more information.




Tetra Bio-Pharma Looks to Make Cannabis Affordable -- CFN Media

Tue, 06 Dec 2016 09:28:03 EST

SEATTLE, WA--(Marketwired - Dec 6, 2016) - CFN Media Group ("CannabisFN"), the leading creative agency and digital media network dedicated to legal cannabis, announces publication of an exclusive interview and story covering Tetra Bio-Pharma Inc.'s (CSE: TBP) (OTC PINK: GRPOF) unique approach in using the natural cannabis plant, rather than synthetics, to develop pharmaceuticals based on the active ingredients in marijuana. The interview is with Ryan Brown, Tetra's Co-Founder and Vice President of Business Development.




Prolacta Bioscience(R) Raises $35 Million in Mezzanine Financing

Tue, 06 Dec 2016 08:30:00 EST

CITY OF INDUSTRY, CA--(Marketwired - Dec 6, 2016) - Prolacta Bioscience®, the nation's leading provider of human milk-based neonatal nutritional products, today announced the closing of a $35 million mezzanine round of financing. The transaction was led by Essex Woodlands and included participation from Aisling Capital, with existing shareholder Health Evolution Partners. As part of the transaction, Martin Sutter, Co-Founder and Managing Director at Essex Woodlands, will join Prolacta's Board of Directors.




Premier Biomedicals Research on its Patent Pending Anti-Cancer Treatment With Metronomic Chemotherapy Recognized for Publication in the Prestigious British Journal of Cancer

Tue, 06 Dec 2016 08:00:00 EST

EL PASO, TX--(Marketwired - Dec 6, 2016) -  Premier Biomedical, Inc. (OTCQB: BIEI) a biotech research public company focused on discovering, developing, and commercializing medical treatments for a wide range of diseases in humans, including innovative therapies for breast cancer as well as potential novel therapies for pain management, announced today that a paper describing their groundbreaking metronomic cancer therapy work in conjunction with development of a patent pending CTLA4 anti-cancer antibody drug at the University of Texas El Paso (UTEP) has been accepted for publication by the prestigious British Journal of Cancer.




Fürsprecher der öffentlichen Gesundheit aus aller Welt sagen dem Tabak an weiteren Fronten den Kampf an

Tue, 06 Dec 2016 07:57:29 EST

WIEN, ÖSTERREICH--(Marketwired - 6. Dezember 2016) - Die Bemühungen, Tabak als Gefahr für die öffentliche Gesundheit zu regulieren, haben sich enorm ausgeweitet. Mediziner und Fürsprecher der öffentlichen Gesundheit sind zusammengekommen, um von Tabakunternehmen ausgehende Bedrohungen durch öffentliche Fürsprache, Maßnahmen im Bereich öffentliche Gesundheit sowie Rentenreformen zurückzuschlagen. Bei einer Pressekonferenz im Rahmen der 17. IASLC World Conference on Lung Cancer (WCLC) präsentierten heute Fürsprecher der öffentlichen Gesundheit aus Brasilien, Malaysia, Irland, Australien und Uruguay verschiedene Strategien, mit denen die globale Bedrohung, die von den Tabakunternehmen ausgeht, unter Kontrolle gebracht werden konnte.




Abeona Therapeutics to Present at 2016 Genetic Rx Boston Biotech Conference at Harvard Medical School

Tue, 06 Dec 2016 07:43:00 EST

NEW YORK, NY and CLEVELAND, OH--(Marketwired - December 06, 2016) - Abeona Therapeutics Inc. (NASDAQ: ABEO), a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening rare genetic diseases, today announced President and CEO, Timothy J. Miller, Ph.D., will participate in a panel discussion at the 2016 Genetic Rx Conference at the Harvard Medical School in Boston, MA.




MDValuate Report Examines Top Reasons Physicians Lose Patients Due to Negative Online Reviews

Tue, 06 Dec 2016 05:30:00 EST

Industry Leader Takes Deep Dive into What Unhappy Patients Are Saying, How to Improve




Elsevier Announces Updates to Two Key Virology Titles, Publication of Seven Additional Virology and Microbiology Books

Tue, 06 Dec 2016 04:00:00 EST

Fifth Editions of "Fenner and White's Medical Virology" and "Fenner's Veterinary Virology" Provide Revised and Expanded Resources for Students, Researchers and Educators




Des défenseurs de la santé publique du monde entier lancent de nouveaux efforts dans la lutte contre le tabac

Mon, 05 Dec 2016 22:34:26 EST

VIENNE, AUTRICHE--(Marketwired - 5 décembre 2016) - Les efforts visant à contrôler le tabac en tant que menace pour la santé publique se sont intensifiés alors que des médecins et des défenseurs de la santé publique se sont unis afin de repousser les menaces posées par les entreprises de tabac via des actions de sensibilisation, des reformes de pension et de santé publique. Aujourd'hui, des défenseurs de la santé publique provenant du Brésil, de Malaisie, d'Irlande, d'Australie et d'Uruguay ont présenté plusieurs stratégies qui se sont avérées efficaces pour enrayer la menace mondiale posée par les entreprises de tabac lors d'une conférence de presse organisée à l'occasion de la 17e Conférence mondiale sur le cancer du poumon (WCLC) de l'IASLC.




Defensores de Saúde Pública de todo o mundo abrem novas frentes na Guerra Contra o Tabaco

Mon, 05 Dec 2016 19:55:32 EST

VIENNA, AUSTRIA--(Marketwired - 5 de dezembro de 2016) - Os esforços para o controle do tabaco como ameaça à saúde pública intensificaram com a união dos médicos e defensores de saúde no combate às ameaças das empresas de tabaco, por meio da defesa pública, saúde pública e reforma de pensão. Defensores de saúde pública do Brasil, Malásia, Irlanda, Austrália e Uruguai apresentaram estratégias diferentes que têm controlado a ameaça global das empresas de tabaco em uma coletiva com a mídia na IASLC 17a Conferência Mundial sobre o Câncer de Pulmão (World Conference on Lung Cancer - WCLC).




Los defensores de la salud pública mundial abren nuevos frentes en la guerra contra el tabaco

Mon, 05 Dec 2016 19:50:27 EST

VIENA, AUSTRIA--(Marketwired - 5 de diciembre de 2016) - Aumentan los esfuerzos por controlar el tabaco como una amenaza a la salud pública al tiempo que médicos y defensores de la salud pública se unen para volver a vencer las amenazas de las tabacaleras a través de la defensa pública, la salud pública y la reforma de las pensiones. Hoy, los defensores de la salud pública de Brasil, Malasia, Irlanda, Australia y Uruguay presentaron diferentes estrategias que han funcionado efectivamente frente a la amenaza mundial de las tabacaleras en una rueda de prensa celebrada en la 17º Conferencia Mundial sobre el Cáncer de Pulmón (WCLC) de la Asociación Internacional para el Estudio del Cáncer de Pulmón (IASLC).




Arch Therapeutics to Present at 9th Annual LD Micro Main Event on December 7, 2016

Mon, 05 Dec 2016 18:03:42 EST

FRAMINGHAM, MA--(Marketwired - Dec 5, 2016) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of the AC5T devices for use in controlling bleeding and fluid loss in order to provide faster and safer surgical and interventional care, today announced that it will be featured as a presenting company at the LD Micro Conference taking place from December 6-8, 2016 at the Luxe Sunset Boulevard Hotel in Los Angeles, California.




InspireMD Announces Change in Presentation Time at LD Micro Main Event Conference to Tuesday, December 6 at 4:30PM PT

Mon, 05 Dec 2016 15:17:39 EST

BOSTON, MA--(Marketwired - Dec 5, 2016) - InspireMD, Inc. (NYSE MKT: NSPR) (NYSE MKT: NSPR.WS) ("InspireMD" or the "Company"), a leader in embolic prevention systems (EPS), neurovascular devices and thrombus management technologies, today announced a change in the Company's presentation time at the LD Micro 9th Annual Main Event on Tuesday, December 6 in Los Angeles, California. Chief Financial Officer, Craig Shore, will now present at 4:30pm PT. Mr. Shore will provide a corporate overview and discuss the Company's proprietary MicroNetT technology, which has been developed to address key issues found with current stenting options.




GetWellNetwork Chief Clinical and Nursing Officer to Speak at National Academy of Medicine Care Culture and Decision-making Innovation Collaborative Meeting

Mon, 05 Dec 2016 14:00:00 EST

Dr. Karen Drenkard to share clinical perspective on framework for patient- and family-engaged care




Global Public Health Advocates Open New Fronts in War on Tobacco

Mon, 05 Dec 2016 11:48:27 EST

VIENNA, AUSTRIA--(Marketwired - December 05, 2016) - Efforts to control tobacco as a public health threat have escalated as clinicians and public health advocates have coalesced to beat back threats from tobacco companies through public advocacy, public health, and pension reform. Today, public health advocates from Brazil, Malaysia, Ireland, Australia, and Uruguay presented different strategies that have effectively reigned in the global threat of tobacco companies at a press briefing held at IASLC 17th World Conference on Lung Cancer (WCLC).




NSU Health Law Program joins International Academy of Medical Ethics & Public Health

Mon, 05 Dec 2016 11:36:31 EST

FORT LAUDERDALE, FL and DAVIE, FL--(Marketwired - December 05, 2016) - "Nova Southeastern University's (NSU's) Health Law Program has joined the International Academy of Medical Ethics and Public Health," according to Law Professor Kathy Cerminara, J.D., LL.M., J.S.D. Professor Cerminara noted, "Biomedical research inspires more and more ethical controversies while advancing our knowledge base. Those combine with the international reach of research protocols to increase the need for cultural competency in both research and treatment, and overlaid on it all are increasingly globalized disease patterns."




Advantis Corp. Acquires Rights to Nugsmasher Line of Rosin Presses

Mon, 05 Dec 2016 09:26:00 EST

NEWPORT BEACH, CA--(Marketwired - Dec 5, 2016) - ADVANTIS CORPORATION (OTC PINK: ADVT), announced that it has acquired rights to be the exclusive distributor and 25% owner of the Nugsmasher line of rosin presses.




GeoVax to Present at Keystone Symposia on Hemorrhagic Fever Viruses

Mon, 05 Dec 2016 09:00:00 EST

ATLANTA, GA--(Marketwired - Dec 5, 2016) - GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company specializing in developing human vaccines, announced today that its Senior Vice President of Research and Development, Dr. Farshad Guirakhoo, will give a talk at the Hemorrhagic Fever Viruses conference sponsored by the Keystone Symposia on Molecular and Cellular Biology. The conference is being held on December 4-8 in Santa Fe, New Mexico.




BriaCell to Present at a Breast Cancer Symposium, and Enters into a Research Agreement with Terasaki Foundation Laboratory

Mon, 05 Dec 2016 08:30:00 EST

BERKELEY, CA and VANCOUVER, BC--(Marketwired - December 05, 2016) - BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX VENTURE: BCT) (OTCQB: BCTXF), a clinical-stage company dedicated to the development of immuno-oncology treatments, today announced that the Company will present the latest development update for BriaVaxT, the Company's proprietary vaccine for advanced breast cancer, at the 39th Annual San Antonio Breast Cancer Symposium in San Antonio, Texas. Additionally, the Company signed a service agreement contract with the Terasaki Foundation Laboratory, a leading non-profit research institution in the area of organ transplantation and immunology, based in Los Angeles.




HCi Viocare enters into discussions with New Balance Athletics, Inc.

Mon, 05 Dec 2016 08:27:07 EST

GLASGOW, SCOTLAND--(Marketwired - Dec 5, 2016) - HCi Viocare (OTCQB: VICA), is pleased to announce that it has entered into discussions with one of the major sport shoes manufacturers in the world, New Balance Athletics, Inc.




Aurora Spine Launches Mobile App

Mon, 05 Dec 2016 08:24:59 EST

CARLSBAD, CALIFORNIA--(Marketwired - Dec. 5, 2016) - Aurora Spine Corporation (TSX VENTURE:ASG) announced today the launch of its new Aurora Spine Mobile App, designed to bring information regarding the new and exciting products being offered by Aurora Spine straight to your mobile device. The App is currently available for Apple, Android, and iPad devices.




Azzad asks pharma companies to reassess drug pricing

Mon, 05 Dec 2016 08:00:31 EST

Socially responsible investment firm joins interfaith coalition to make health care more affordable




Aktiver Wissensaustausch und Gesundheitsvorsorgemodelle in Gemeinden ergänzen Forschung und klinische Pflege ? darüber wurden sich weltweite Experten in Wien (Österreich) auf der von der Internationalen Vereinigung für das Studium von Lungenkrebs veranstal

Sun, 04 Dec 2016 20:14:05 EST

WIEN, ÖSTERREICH--(Marketwired - 4. Dezember 2016) - Lungenkrebsforscher und Patientenvertreter aus aller Welt betonten heute, dass neue Behandlungsmodelle sowie der aktive Wissensaustausch über Krebsbehandlungsmöglichkeiten eine wichtige Rolle bei der Bekämpfung von Lungenkrebs spielen. Diese Aussage wurde am ersten Tag der von der IASLC veranstalteten 17. Welt-Lungenkrebs-Konferenz (World Conference on Lung Cancer, WCLC) in Wien (Österreich) verlautet.




Les experts mondiaux de la recherche et des soins cliniques complémentaires relatifs aux modèles de soins médicaux associatifs et communautaires se réunissent à Vienne, en Autriche, à l'occasion de la dix-septième édition de la Conférence mondiale sur le c

Sun, 04 Dec 2016 20:04:23 EST

VIENNE, AUTRICHE--(Marketwired - 4 décembre 2016) - Un groupe composé de chercheurs et de membres d'associations de défense des patients atteints de cancer du poumon a souligné aujourd'hui que les nouveaux modèles de prestation et de communication des soins relatifs au cancer jouaient un rôle important dans la lutte contre cette forme de pathologie cancéreuse. Leurs observations ont été émises lors de la première journée de la 17e conférence mondiale sur le cancer du poumon (WCLC) de l'IASLC, organisée dans la capitale autrichienne.




Modelos de defensa y atención sanitaria a la comunidad complementan la investigación y la atención clínica; expertos mundiales se congregan en Viena, Austria, en la 17 Conferencia Mundial sobre Cáncer de Pulmón Mundial de la Asociación Internacional para e

Sun, 04 Dec 2016 19:23:53 EST

VIENA, AUSTRIA--(Marketwired - 4 de diciembre de 2016) - Investigadores y defensores de pacientes con cáncer de pulmón de todo el mundo enfatizaron hoy que los nuevos modelos de prestación de atención y comunicación en la atención oncológica desempeñan un papel importante en la lucha contra el cáncer de pulmón. Estos son los comentarios del primer día de la 17ª Conferencia Mundial sobre Cáncer de Pulmón (WCLC) (WCLC) que tiene lugar en Viena, Austria.




Modelos de Defesa de Cuidado de Saúde Comunitário complementam a Convenção de Experts Mundiais de Pesquisa e Cuidado Clínico em Viena, Áustria da 17a. Conferência Mundial de Câncer de Pulmão da International Association for the Study of Lung Cancer

Sun, 04 Dec 2016 15:58:15 EST

VIENNA, AUSTRIA--(Marketwired - 4 de dezembro de 2016) - Pesquisadores e defensores de pacientes de câncer de pulmão de todo o mundo enfatizam que os novos modelos de cuidado e de comunicação sobre o câncer de pulmão têm um papel importante na luta contra o câncer de pulmão. Esta observação foi feita no primeiro dia da IASLC 17th World Conference on Lung Cancer (Conferência Mundial de Câncer de Pulmão - WCLC) em Viena, Áustria.




Advocacy and Community Health Care Models Complement Research and Clinical Care World Experts Convene in Vienna, Austria at the International Association for the Study of Lung Cancer 17th World Conference on Lung Cancer

Sun, 04 Dec 2016 07:52:09 EST

VIENNA, AUSTRIA--(Marketwired - December 04, 2016) - Global lung cancer researchers and patient advocates today emphasized that new models of delivering care and communicating about cancer care play an important role in the fight against lung cancer. Their remarks come on the first day of the IASLC 17th World Conference on Lung Cancer (WCLC) in Vienna, Austria.




Inicia Conferencia Internacional sobre el Cáncer de Pulmón, presenta avances decisivos en la investigación del cáncer de pulmón y la salud pública

Sat, 03 Dec 2016 04:00:00 EST

VIENA, AUSTRIA--(Marketwired - 3 de diciembre de 2016) - La Asociación Internacional del Estudio del Cáncer de Pulmón (IASLC) inicia la IASLC 17ava. Conferencia Mundial del Cáncer de Pulmón (WCLC) mañana, el principal encuentro mundial dedicado al cáncer de pulmón y otras malignidades torácicas. La IASLC 17ava. WCLC cubrirá todos los aspectos sobre el control de los cánceres de pulmón, mesotelioma, carcinoma tímico, y otras malignidades torácicas. Más de 6.000 investigadores, médicos, especialistas, enfermeras, activistas y pacientes asistirán para obtener mayor información acerca de los avances en la investigación y ensayos clínicos del cáncer de pulmón en todo el mundo. La IASLC 17ava. WCLC se realiza en el Messe Wien Exhibition & Congress Center en Viena, Austria, del 4 al 7 de diciembre de 2016.




Conferência Mundial da Associação Internacional de Estudo de Câncer de Pulmão tem início compartilhando os principais avanços de pesquisa e saúde pública do câncer de pulmão

Sat, 03 Dec 2016 04:00:00 EST

VIENNA, AUSTRIA--(Marketwired - 3 de dezembro de 2016) - The International Association for the Study of Lung Cancer (IASLC) dará início a IASLC 17th World Conference on Lung Cancer (WCLC) amanhã, realizando a maior conferência dedicada ao câncer de pulmão e outras doenças malignas do tórax. A IASLC 17th WCLC abrangerá todos os aspectos da gestão de câncer de pulmão, mesotelioma, tímica e outras malignidades torácicas. Mais de 6.000 pesquisadores, médicos, especialistas, enfermeiros, defensores e pacientes participarão do evento para saber mais sobre os avanços na pesquisa e testes clínicos de câncer de pulmão em todo o mundo. A IASLC 17th WCLC será realizada na Messe Wien Exhibition & Congress Center em Viena, Áustria entre 4-7 de dezembro de 2016.




International Conference on Lung Cancer Research Kicks Off; Key Advances in Lung Cancer Research and Public Health to be Shared

Sat, 03 Dec 2016 04:00:00 EST

VIENNA, AUSTRIA--(Marketwired - December 03, 2016) - The International Association for the Study of Lung Cancer (IASLC) kicks off the IASLC 17th World Conference on Lung Cancer (WCLC) tomorrow, the world's largest meeting dedicated to lung cancer and other thoracic malignancies. The IASLC 17th WCLC will cover all aspects of the management of lung cancers, mesothelioma, thymic, and other thoracic malignancies. More than 6,000 researchers, physicians, specialists, nurses, advocates, and patients will be in attendance to learn more about advancements in lung cancer research and clinical trials across the globe. The IASLC 17th WCLC takes place at the Messe Wien Exhibition & Congress Center in Vienna, Austria Dec. 4-7, 2016.




Coup d'envoi de la Conférence internationale pour la recherche sur le cancer du poumon : de grandes avancées en matière de recherche et de programmes de santé publique sur le cancer du poumon seront communiquées

Sat, 03 Dec 2016 04:00:00 EST

VIENNE, AUTRICHE--(Marketwired - 3 décembre 2016) - L'Association internationale pour l'étude du cancer du poumon (IASLC) donne demain le coup d'envoi de la 17ème conférence WCLC (World Conference on Lung Cancer), le plus vaste colloque au monde consacré au cancer du poumon et aux autres tumeurs thoraciques. Au cours de sa 17ème édition, la WCLC couvrira tous les aspects liés à la prise en charge du cancer du poumon, des mésothéliomes, des tumeurs du thymus et des autres tumeurs thoraciques. Plus de 6 000 chercheurs, médecins, spécialistes, personnels infirmiers, militants et patients y participeront afin d'en apprendre davantage sur les avancées de la recherche sur le cancer du poumon et sur les essais cliniques réalisés à travers le monde. La 17ème conférence WCLC se tiendra au centre d'exposition et de conférence de Vienne (Messe Wien), en Autriche, du 4 au 7 décembre 2016.




Internationale Konferenz zur Lungenkrebsforschung startet; es wird über wichtige Fortschritte bei der Lungenkrebsforschung und Volksgesundheit berichtet

Sat, 03 Dec 2016 04:00:00 EST

WIEN, ÖSTERREICH--(Marketwired - 3. Dezember 2016) - The International Association for the Study of Lung Cancer (die Internationale Gesellschaft für das Studium von Lungenkrebs, IASLC) läutet morgen die 17. IASLC-Weltkonferenz zu Lungenkrebs (WCLC) ein, die weltweit größte Tagung zu Lungenkrebs und anderen thorakalen Tumoren. Die 17. IASLC-WCLC deckt alle Aspekte des Umgangs mit Lungenkrebs, Mesotheliom, Thymus- und anderen thorakalen Tumoren ab. Mehr als 6.000 Forscher, Ärzte, Spezialisten, Krankenschwestern, Rechtsanwälte und Patienten werden teilnehmen, um mehr über die Fortschritte in der Lungenkrebsforschung und über klinische Studien auf der ganzen Welt zu erfahren. Die 17. IASLC-WCLC findet im Ausstellungs- und Kongresszentrum "Messe Wien" in Wien vom 4. bis 7. Dezember 2016 statt.




New Advanced Antimicrobial Stewardship Solution from Wolters Kluwer Helps Healthcare Organizations Improve Clinical Outcomes, Reduce Costs

Fri, 02 Dec 2016 09:30:00 EST

Expanded Pharmacy OneSource Sentri7 Offering Powers High-Performing Antimicrobial Stewardship Programs to Address Growing Concerns Over Resistant Organisms




eWellness Announces Signing of Initial Third Party PT Clinic for its PHZIO Telemedicine Platform

Fri, 02 Dec 2016 08:45:00 EST

CULVER CITY, CA--(Marketwired - Dec 2, 2016) - eWellness Healthcare Corporation, (OTCQB: EWLL) is the first physical therapy telemedicine company to offer insurance reimbursable real-time distance monitored physical therapy (PT) treatments. The Company is pleased to announce the Company successfully signed its initial 3rd party PT clinic for the use of its PHZIO Tele- rehabilitation Platform. The agreement is with Back to Motion PT located in Denver Colorado. Back to Motion PT is one of our current universe of up to 30 beta site PT clinics to begin using our PHZIO system. The Company has a significant backlog of PT clinics who have indicated a high interest in using our PHZIO platform.




Brown Technical Media Corp., a division of Panther Biotechnology, Signs a Binding Letter of Intent to Acquire Premier Purchasing and Alliance LLC

Fri, 02 Dec 2016 06:00:00 EST

HOUSTON, TX--(Marketwired - Dec 2, 2016) - Brown Technical Media Corp., a division of Panther Biotechnology, Inc. (OTC PINK: PBYA) is pleased to announce today that it has executed a binding letter of intent to acquire Premier Purchasing and Alliance LLC, a New York limited liability company also known as National Electrical Wholesale Providers (NEWP). NEWP is in the business of servicing electrical wholesalers throughout the United States with electrician related study material including the National Electrical Code, providing a complete line of printed reference materials in addition to eBooks, downloadable digital formatting, and mobile applications, to all distributors. NEWP has significant corporate accounts with electrical wholesale conglomerates making them one the largest wholesalers of National Electrical Codes in the US. NEWP also covers HVAC, Plumbing, Industrial and Residential trade reference materials with online training for product education, certification and current code practices.